Blend Therapeutics Receives $2,800,000 Series A Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=04f5e849-4114-4c38-9a60-9d295995e112&Preview=1 -
Date
1/9/2012 -
Company Name
Blend Therapeutics -
Mailing Address
134 Coolidge Avenue Watertown, MA 02472 -
Company Description
Blend is pioneering controlled combination medicines that overcome the limitations of conventional combination therapy through their unprecedented ability to hit distinct disease pathways with multiple drugs in concert—at the desired sites, at the most effective concentrations, and for the right durations—to drive optimal effects from each drug on the disease process. -
Website
http://www.blendtx.com -
Transaction Type
Venture Equity -
Transaction Amount
$2,800,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Flagship Ventures -
Venture Investor
Undisclosed
